13th Tumour Models London Summit 2024, December 4-5, 2024
Conference
genOway presentation
Event
-
December 4, 2024
genOway's presentation on Wednesday, December 4, 2024 | 1:30 p.m. GMT:
Presence of myeloid and lymphoid cells are key for translational tumor biology, efficacy and safety assessment in humanized mouse models
- Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Investigating human immune cell recruitment into tumor microenvironment
- Studying myeloid cell functionality and their contribution to translatable safety assessment of therapies
13th Tumour Models London Summit 2024, December 4-5, 2024
Get in touch about
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Tailor-made solutions adapted to scientific questions
Robust validation data on catalog models
Comprehensive dataset package
Generated with biopharma partners and in-house
Customer care
Scientific follow-up and advice along the project
Collaborative approach for problem solving and development of innovative models
Easy and fast access to models
Breeding facilities in US and Europe
Certified health status from professional breeders